PORTFOLIO COMPANIES




prior investment

HealthpointCapital is a values-driven, research-based private equity firm
exclusively focused on the musculoskeletal sector — specifically orthopedics and dental. HealthpointCapital manages in excess of $750 million of institutional capital.

Orthopedic & Dental Industry Research Most Recent Blog Articles Complete Archive »

Dental News Roundup July 2010 BY LAUREN UZDIENSKI

Align, Biomet, Dentsply and Zimmer report dental sales . . . Astra Tech augments Atlantis patient-specific abutment line . . . Biomet 3i and Renishaw to collaborate on digital solutions . . . BIOLASE announces cost-cutting initiatives and organizational changes . . . DTI appoints Russell Olsen as Senior Vice President of Sales, Marketing and Service . . . Straumann's CFO steps down more

Musculoskeletal News Roundup 29-Jul-10 BY LAUREN UZDIENSKI

CNMD, IART, NUVA, OFIX, Synthes report 2Q:10 sales . . . Axiomed raises $14.5M . . . China Kanghui Holdings to go public . . . FDA panel votes in favor of Medtronic's Amplify . . . FDA approves Orthovita's new collagen processing facility . . . curasan seeking distribution partners for ATR . . . TranS1 launches next-gen AxiaLIF 2L+ system . . . Ortho Kinematics enrolling study more

FDA Panel Recommends Medtronic's Amplify BY LAUREN UZDIENSKI

An FDA panel voted 6-5 yesterday in favor of approving Medtronic's Amplify, a BMP-2 with a different formulation and carrier than InFuse. Heading into the meeting, concerns circulated over a higher incidence of cancer in patients treated with Amplify, though the panel ultimately voted 9-4 in support of safety (with 1 abstention) and 10-3 (with 1 abstention) on efficacy. more

Sen. Franken, AdvaMed Lobby Congress for Pediatric Device Incentives BY LAUREN UZDIENSKI

Sen. Al Franken and AdvaMed faced Congress last week, urging legislators to increase financial incentives for devicemakers addressing pediatric patient populations. more